The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Arven Ilac Sanayi Ve Ticaret competitive analysis

Loading summary...

Latest oppositions filed by Arven Ilac Sanayi Ve Ticaret

Explore patent oppositions filed by Arven Ilac Sanayi Ve Ticaret against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2400950
Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUPFeb 14, 2020

Latest patents of Arven Ilac Sanayi Ve Ticaret opposed by its competitors

Explore Arven Ilac Sanayi Ve Ticaret's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2682099
Sep 2, 2020Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists3
EP2957552
Jan 22, 2020Vilanterol Formulations3
EP2957551
Jan 15, 2020Dry Powder Formulations Comprising Vilanterol4
EP3166641
Sep 12, 2018A Process For The Preparation Of Formulations For Inhalation1

Latest PTAB cases involving Arven Ilac Sanayi Ve Ticaret

Discover the latest PTAB cases involving Arven Ilac Sanayi Ve Ticaret, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Arven Ilac Sanayi Ve Ticaret with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARVEN ILAC SANAYI VE TICARET111 - -
BECK GREENER12 - - -
GILL JENNINGS & EVERY18 - - -
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB17 - - -